Skip to main content

Day: September 17, 2025

Form 8.3 – [IQE PLC – 16 09 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) services MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, the leading provider of Transcranial Magnetic Simulation (TMS), announced that New York State Medicaid will begin covering TMS services for adults diagnosed with major depressive disorder (MDD). The coverage will take effect October 1, 2025, for fee-for-service Medicaid members, and November 1, 2025, for those enrolled in Medicaid Managed Care Plans. “This decision by New York State Medicaid reflects the growing recognition of TMS...

Continue reading

Birchtech to Present at WeBull “Small-Cap Insights” Webinar on September 24, 2025

CORSICANA, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) — Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and water treatment, today announced that management has been invited to present at the WeBull Small-Cap Insights Webinar taking place on September 24, 2025. CEO Richard MacPherson is scheduled to present at the live event as follows. Following the webinar, a replay link to the presentation will be shared on the Birchtech investor relations website. WeBull Small-Cap Insights WebinarDate: Wednesday, September 24, 2025Time: 2:00 p.m. Eastern timeRegistration Link: WeBull Small-Cap Insights Webinar MacPherson said: “In this, our second webinar with WeBull, a leading retail investor platform, I will highlight how...

Continue reading

Banzai to Present at the Emerging Growth Conference on Wednesday, September 24, 2025

SEATTLE, Sept. 17, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that Joe Davy, Founder & CEO, will present at the Emerging Growth Conference on Wednesday, September 24, 2025. Emerging Growth Conference Details:Date: Wednesday, September 24, 2025Time: 3:40 p.m. Eastern Time (12:40 p.m. Pacific Time)Webcast Registration: https://goto.webcasts.com/starthere.jsp?ei=1717091&tp_key=c78a55764a&sti=bnziA webcast of the presentation will also be available under the Events section of the Company’s investor relations website linked here. To schedule a one-on-one investor meeting with Banzai management, please contact your Emerging Growth Conference representative...

Continue reading

Fluent Named to Crain’s New York Business 2025 Best Places to Work List

NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading commerce media company, today announced its inclusion on Crain’s New York Business 2025 Best Places to Work list. This recognition highlights Fluent’s ongoing commitment to cultivating a workplace where performance, innovation, collaboration, and community thrive. The annual Crain’s list identifies companies across industries that excel in areas such as employee engagement, workplace culture, benefits, and professional development. Rankings are determined through confidential employee surveys and employer questionnaires assessing everything from compensation and career growth to flexibility and corporate citizenship. “At Fluent, our people are the driving force behind our growth and success,” said Don Patrick, CEO of Fluent. “We’ve worked hard to...

Continue reading

Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research

Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to reprogram the ovarian tumor microenvironment and advance toward clinical trials CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced preclinical data will be presented at the inaugural AACR Special Conference in Cancer Research: Advances in Ovarian Cancer Research. The oral presentation, taking place on September 20, 2025 in Denver, is titled “Gene-modified iPS-derived MSC restore a ‘Hot’ immune microenvironment in high-grade serous ovarian cancer.” The presentation will highlight new preclinical findings from Ernexa’s lead program, ERNA-101, a synthetic, off-the-shelf...

Continue reading

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly blind Cortigent’s new Orion® artificial vision system, developed to treat blindness caused by common conditions, has successfully completed a 6-year Early Feasibility Study Cortigent is developing a new medical device aimed at improving recovery of arm and hand motion in patients with paralysis due to stroke Vivani to sharpen focus on development of miniature, ultra long-acting GLP-1 implants for weight loss management and treatment of type 2 diabetes with once or twice-yearly administration ALAMEDA, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) — Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage...

Continue reading

Safety Shot Announces Strategic Board Refresh to Align with New Corporate Vision

Company Appoints New Directors with Deep Expertise in Venture Capital, Financial Due Diligence, and Bitcoin Mining to Guide Next Phase of Growth SCOTTSDALE, AZ, Sept. 17, 2025 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) today announced a strategic refresh of its Board of Directors with the appointment of three new members: Connor Klein, an investment partner at New Form Capital; Stacey Duffy, a seasoned financial due diligence and transaction advisory expert; and Jamie McAvity, co-founder and CEO of Bitcoin miner Cormint, Inc. The new appointments are designed to provide the Company with enhanced expertise in digital assets, capital markets, and high-growth operations as it executes on its new strategy centered around its subsidiary, BONK Holdings LLC. Following these changes, the Board of Directors will be composed of...

Continue reading

Progressive Reports August 2025 Results

MAYFIELD VILLAGE, OHIO, Sept. 17, 2025 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended August 31, 2025:  August(millions, except per share amounts and ratios; unaudited)   2025     2024   ChangeNet premiums written $ 7,199   $ 6,507   11   %Net premiums earned $ 7,036   $ 5,968   18   %Net income $ 1,220   $ 935   30   %Per share available to common shareholders $ 2.07   $ 1.59   30   %Total pretax net realized gains (losses) on securities $ 78   $ 104   (25 ) %Combined ratio   83.1     85.5   (2.4 ) pts.Average diluted equivalent common shares   588.1     587.6   0   %  August 31,(thousands; unaudited)   2025     2024     % Change  Policies in Force                  Personal Lines                  Agency – auto   10,575     9,278     14  Direct...

Continue reading

FirstService Expands Commercial Roofing Geographic Footprint in Key Markets

Roofing Corp of America Acquires Florida-Based Springer-Peterson and California-Based A-1 All American TORONTO, Sept. 17, 2025 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that its subsidiary, Roofing Corp of America (“RCA”), has acquired Springer-Peterson Roofing & Sheet Metal (“Springer-Peterson”) and A-1 All American Roofing Co. (“A-1 All American”). These two tuck-under acquisitions further enhance RCA’s presence in key markets within the U.S. Sun Belt region. The existing management teams of both businesses have retained minority equity interests and will continue to oversee their respective day-to-day operations. Terms of the two transactions were not disclosed. Founded in 1982 with its head office in Lakeland, Florida, Springer-Peterson is the leading provider of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.